Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Caraceni, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caraceni, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey

Augusto Caraceni

Cinzia Martini

Ernesto Zecca

Neurology Unit-Pain Therapy and Palliative Care Unit, National Cancer Institute of Milan, Via Venezian 1, Milan

Russell K Portenoy

Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York

a Working Group of an IASP Task Force on Cancer Pain

Breakthrough pain (BKP) is a transitory flare of pain that occurs on a background of relatively well controlled baseline pain. Previous surveys have found that BKP is highly prevalent among patients with cancer pain and predicts more severe pain, pain-related distress and functional impairment, and relatively poor quality of life. An international group of investigators assembled by a task force of the International Association for the Study of Pain (IASP) evaluated the prevalence and characteristics of BKP as part of a prospective, cross-sectional survey of cancer pain. Fifty-eight clinicians in 24 countries evaluated a total of 1095 patients with cancer pain using patient-rated items from the Brief Pain Inventory (BPI) and observer-rated measures. The observer-rated information included demographic and tumor-related data, the occurrence of BKP, and responses on checklists of pain syndromes and pathophysiologies. The clinicians reported BKP in 64.8% of patients. Physicians from English-speaking countries were significantly more likely to report BKP than other physicians. BKP was associated with higher pain scores and functional interference on the BPI. Multivariate analysis showed an independent association of BKP with the presence of more than one pain, a vertebral pain syndrome, pain due to plexopathy, and English-speaking country. These data confirm the high prevalence of BKP, its association with more severe pain and functional impairment, and its relationship to specific cancer pain syndromes. Further studies are needed to characterize subtypes of BKP. The uneven distribution of BKP reporting across pain specialists from different countries suggests that more standardized methods for diagnosing BKP are needed.

Key Words: breakthrough pain • cancer pain • cancer pain classi"cation • cancer pain syndromes • IASP Task Force on Cancer Pain

Palliative Medicine, Vol. 18, No. 3, 177-183 (2004)
DOI: 10.1191/0269216304pm890oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
J. Devulder, A. Jacobs, U. Richarz, and H. Wiggett
Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain
Br. J. Anaesth., October 1, 2009; 103(4): 576 - 585.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
A. Knudsen, N Aass, R Fainsinger, A Caraceni, P Klepstad, M Jordhoy, M. Hjermstad, and S Kaasa
Classification of pain in cancer patients - a systematic literature review
Palliative Medicine, June 1, 2009; 23(4): 295 - 308.
[Abstract] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
L. Guilherme Soares and V. W. Chan
Review Article: The Rationale for a Multimodal Approach in the Management of Breakthrough Cancer Pain: A Review
American Journal of Hospice and Palliative Medicine, November 1, 2007; 24(5): 430 - 439.
[Abstract] [PDF]


Home page
Ann OncolHome page
M. van den Beuken-van Everdingen, J. de Rijke, A. Kessels, H. Schouten, M van Kleef, and J Patijn
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
Ann. Onc., September 1, 2007; 18(9): 1437 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
S. Kay, E. Husbands, J.H. Antrobus, and D. Munday
Provision for advanced pain management techniques in adult palliative care: a national survey of anaesthetic pain specialists
Palliative Medicine, June 1, 2007; 21(4): 279 - 284.
[Abstract] [PDF]


Home page
Palliat MedHome page
A. Holtan, N. Aass, T. Nordoy, D. F. Haugen, S. Kaasa, W. Mohr, and U. E Kongsgaard
Prevalence of pain in hospitalised cancer patients in Norway: a national survey
Palliative Medicine, January 1, 2007; 21(1): 7 - 13.
[Abstract] [PDF]


Home page
Palliat MedHome page
C. L Nekolaichuk, R. L Fainsinger, and P. G Lawlor
A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain
Palliative Medicine, September 1, 2005; 19(6): 466 - 476.
[Abstract] [PDF]